155 related articles for article (PubMed ID: 14766129)
1. Vancomycin does not benefit persistently febrile neutropenic people with cancer.
Wade JC; Glasmacher A
Cancer Treat Rev; 2004 Feb; 30(1):119-26. PubMed ID: 14766129
[No Abstract] [Full Text] [Related]
2. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
4. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
Sipsas NV; Bodey GP; Kontoyiannis DP
Cancer; 2005 Mar; 103(6):1103-13. PubMed ID: 15666328
[TBL] [Abstract][Full Text] [Related]
5. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
[TBL] [Abstract][Full Text] [Related]
6. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
Roy S; Higareda I; Angel-Muller E; Ismail M; Hague C; Adeyi B; Woods GL; Teppler H;
Infect Dis Obstet Gynecol; 2003; 11(1):27-37. PubMed ID: 12839630
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
[TBL] [Abstract][Full Text] [Related]
8. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Cometta A; Kern WV; De Bock R; Paesmans M; Vandenbergh M; Crokaert F; Engelhard D; Marchetti O; Akan H; Skoutelis A; Korten V; Vandercam M; Gaya H; Padmos A; Klastersky J; Zinner S; Glauser MP; Calandra T; Viscoli C;
Clin Infect Dis; 2003 Aug; 37(3):382-9. PubMed ID: 12884163
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A
Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546
[TBL] [Abstract][Full Text] [Related]
13. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Simon A; Gröger N; Wilkesmann A; Hasan C; Wiszniewsky G; Engelhart S; Kramer MH; Bode U; Ammann RA; Fleischhack G
Int J Antimicrob Agents; 2006 Nov; 28(5):417-22. PubMed ID: 17046210
[TBL] [Abstract][Full Text] [Related]
14. Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults.
Roohullah A; Moniwa A; Wood C; Humble M; Balm M; Carter J; Weinkove R
Intern Med J; 2013 Oct; 43(10):1151-4. PubMed ID: 23800137
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of piperacillin-tazobactam for febrile neutropenic patients in Japan].
Miyazaki K; Kamata H; Kimura H; Okina S; Ishii R; Osaka M; Danbara M; Horie R; Higashihara M
Rinsho Ketsueki; 2012 Jul; 53(7):686-90. PubMed ID: 22975770
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
Le Guyader N; Auvrignon A; Vu-Thien H; Portier E; Tabone MD; Leverger G
Support Care Cancer; 2004 Oct; 12(10):720-4. PubMed ID: 15138864
[TBL] [Abstract][Full Text] [Related]
17. Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Karakurt DG; Demirsoy U; Corapcioglu F; Oncel S; Karadogan M; Arisoy ES
Pediatr Hematol Oncol; 2014 Aug; 31(5):415-24. PubMed ID: 24499434
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Ichikawa M; Suzuki D; Ohshima J; Cho Y; Kaneda M; Iguchi A; Ariga T
Pediatr Blood Cancer; 2011 Dec; 57(7):1159-62. PubMed ID: 21438131
[TBL] [Abstract][Full Text] [Related]
19. Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
Ammann RA; Simon A; de Bont ES
Pediatr Blood Cancer; 2005 Sep; 45(3):244-7. PubMed ID: 15747334
[No Abstract] [Full Text] [Related]
20. Optimization of continuous infusion of piperacillin-tazobactam in children with fever and neutropenia.
Delvallée M; Mazingue F; Abouchahla W; Delebarre M; Wallet F; Courcol R; Kipnis E; Dessein R
Pediatr Infect Dis J; 2013 Sep; 32(9):962-4. PubMed ID: 23629023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
